Brief: Vivesto Signs Deal With Kazia Therapeutics To Acquire Full Cantrixil Rights
31/03/2025 07:15
March 31 (Reuters) - Vivesto AB VIVE.ST: VIVESTO SIGNS DEAL WITH KAZIA THERAPEUTICS TO ACQUIRE FULL CANTRIXIL RIGHTS TO ACQUIRE FULL RIGHTS, INCLUDING ALL INTELLECTUAL PROPERTY AND TRADEMARKS RIGHTS FOR DRUG CANDIDATE CANTRIXIL FOR 1 MUSD Source text: ID:nMFN3Zy89Y Further company coverage: VIVE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))